[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Florio et al., 2018 - Google Patents

Sustained expression of negative regulators of myelination protects Schwann cells from dysmyelination in a Charcot–Marie–Tooth 1B mouse model

Florio et al., 2018

View PDF @Free from Publisher
Document ID
14591354625340489111
Author
Florio F
Ferri C
Scapin C
Feltri M
Wrabetz L
D'Antonio M
Publication year
Publication venue
Journal of Neuroscience

External Links

Snippet

Schwann cell differentiation and myelination in the PNS are the result of fine-tuning of positive and negative transcriptional regulators. As myelination starts, negative regulators are downregulated, whereas positive ones are upregulated. Fully differentiated Schwann …
Continue reading at www.jneurosci.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Similar Documents

Publication Publication Date Title
Florio et al. Sustained expression of negative regulators of myelination protects Schwann cells from dysmyelination in a Charcot–Marie–Tooth 1B mouse model
Lin et al. miR-23 regulation of lamin B1 is crucial for oligodendrocyte development and myelination
Tang et al. VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for α-synuclein degradation and prevention of pathogenesis of Parkinson's disease
Villaescusa et al. A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease
Segura et al. The long form of Fas apoptotic inhibitory molecule is expressed specifically in neurons and protects them against death receptor-triggered apoptosis
Kawai et al. Area-specific regulation of quiescent neural stem cells by Notch3 in the adult mouse subependymal zone
Wang et al. Requirement for microglia for the maintenance of synaptic function and integrity in the mature retina
Su et al. Mutant α-synuclein overexpression mediates early proinflammatory activity
Sun et al. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin
Lee et al. Regulator of G-protein signaling-10 negatively regulates NF-κB in microglia and neuroprotects dopaminergic neurons in hemiparkinsonian rats
D’Antonio et al. Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice
Aimé et al. Trib3 is elevated in Parkinson's disease and mediates death in Parkinson's disease models
Sen et al. ApoE4 and Aβ oligomers reduce BDNF expression via HDAC nuclear translocation
Boyer et al. Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy
Seijffers et al. ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration
Rohe et al. Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression
Ryan et al. Microtubule stability, Golgi organization, and transport flux require dystonin-a2–MAP1B interaction
Chang et al. Novel regulatory mechanisms for the SoxC transcriptional network required for visual pathway development
Zhang et al. TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
Zhao et al. Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins
Sidoli et al. Ablation of Perk in Schwann cells improves myelination in the S63del Charcot-Marie-Tooth 1B mouse
Ryu et al. Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss
Kato et al. Prox1 inhibits proliferation and is required for differentiation of the oligodendrocyte cell lineage in the mouse
Staats et al. Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice
MacIsaac et al. Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-out